BFC Planning’s Abivax ABVX Stock Holding History
Bought
Maintained
Sold
Other funds holding ABVX
BFC Planning's ABVX Position: Q3 2026 in Review
BFC Planning reduced its Abivax (ABVX) stake by 6% in Q3 2026, selling an estimated $10.5K and leaving 1,352 shares worth $134K. The position accounts for 0.01% of the portfolio, ranked #1114.
BFC Planning first reported a position in ABVX in Q4 2025 and has held it in 4 quarters since. The position peaked at $199K in Q4 2025. 218 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.
- BFC Planning held 1,352 shares of Abivax worth $134K as of Q3 2026.
- BFC Planning sold 87 Abivax shares in Q3 2026, an estimated $10.5K.
- Abivax made up 0.01% of BFC Planning's portfolio in Q3 2026, its #1114 holding.
- BFC Planning first reported a position in Abivax in Q4 2025 and has held it in 4 quarters since.
- BFC Planning's Abivax position peaked at $199K in Q4 2025.
- 218 funds tracked by Wall St. Rank held Abivax as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.